

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 7.57919996 |
| 2 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.06632074 |
| 3 | glutamate secretion (GO:0014047) | 6.25372522 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 6.17688991 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 6.07572570 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.67077614 |
| 7 | regulation of synaptic vesicle transport (GO:1902803) | 5.28902898 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.24037786 |
| 9 | cellular potassium ion homeostasis (GO:0030007) | 5.18784967 |
| 10 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.16384055 |
| 11 | sodium ion export (GO:0071436) | 5.05560440 |
| 12 | neurotransmitter secretion (GO:0007269) | 4.90532169 |
| 13 | locomotory exploration behavior (GO:0035641) | 4.68638969 |
| 14 | L-amino acid import (GO:0043092) | 4.61823481 |
| 15 | cerebellar granule cell differentiation (GO:0021707) | 4.57852388 |
| 16 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.31698029 |
| 17 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.24742719 |
| 18 | regulation of ARF protein signal transduction (GO:0032012) | 4.23367563 |
| 19 | neuronal action potential propagation (GO:0019227) | 4.18163579 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.15914622 |
| 21 | neurotransmitter transport (GO:0006836) | 3.98738820 |
| 22 | positive regulation of synapse maturation (GO:0090129) | 3.97924381 |
| 23 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.92471886 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.91633169 |
| 25 | exploration behavior (GO:0035640) | 3.88014709 |
| 26 | amino acid import (GO:0043090) | 3.87756141 |
| 27 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.84022040 |
| 28 | vocalization behavior (GO:0071625) | 3.81690736 |
| 29 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.69926618 |
| 30 | potassium ion import (GO:0010107) | 3.65889335 |
| 31 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.65665170 |
| 32 | positive regulation of membrane potential (GO:0045838) | 3.63827729 |
| 33 | regulation of neurotransmitter secretion (GO:0046928) | 3.58217612 |
| 34 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.55472884 |
| 35 | regulation of neurotransmitter levels (GO:0001505) | 3.53202526 |
| 36 | synaptic transmission, glutamatergic (GO:0035249) | 3.52329466 |
| 37 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.52150510 |
| 38 | potassium ion homeostasis (GO:0055075) | 3.50716945 |
| 39 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.50075458 |
| 40 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.47775271 |
| 41 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.46755760 |
| 42 | regulation of synaptic plasticity (GO:0048167) | 3.45601367 |
| 43 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.45288887 |
| 44 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.34934734 |
| 45 | synaptic vesicle endocytosis (GO:0048488) | 3.33254699 |
| 46 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.31485432 |
| 47 | neuronal ion channel clustering (GO:0045161) | 3.29117352 |
| 48 | neuron-neuron synaptic transmission (GO:0007270) | 3.28764053 |
| 49 | dendritic spine morphogenesis (GO:0060997) | 3.27649078 |
| 50 | long-term memory (GO:0007616) | 3.27646774 |
| 51 | neuromuscular process controlling balance (GO:0050885) | 3.26595146 |
| 52 | regulation of synapse structural plasticity (GO:0051823) | 3.24786824 |
| 53 | cell communication by electrical coupling (GO:0010644) | 3.24126721 |
| 54 | proline transport (GO:0015824) | 3.24048728 |
| 55 | glutamate receptor signaling pathway (GO:0007215) | 3.23745105 |
| 56 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.22929696 |
| 57 | regulation of synapse maturation (GO:0090128) | 3.21487933 |
| 58 | regulation of neurotransmitter transport (GO:0051588) | 3.18378547 |
| 59 | activation of protein kinase A activity (GO:0034199) | 3.16335753 |
| 60 | protein localization to synapse (GO:0035418) | 3.14565513 |
| 61 | negative regulation of cell killing (GO:0031342) | 3.14307836 |
| 62 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.14307836 |
| 63 | regulation of postsynaptic membrane potential (GO:0060078) | 3.14066005 |
| 64 | neuromuscular process controlling posture (GO:0050884) | 3.10517571 |
| 65 | regulation of vesicle fusion (GO:0031338) | 3.07491832 |
| 66 | long-term synaptic potentiation (GO:0060291) | 3.06932795 |
| 67 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.06544277 |
| 68 | gamma-aminobutyric acid transport (GO:0015812) | 3.06525132 |
| 69 | axon ensheathment in central nervous system (GO:0032291) | 3.05677178 |
| 70 | central nervous system myelination (GO:0022010) | 3.05677178 |
| 71 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.03849081 |
| 72 | regulation of exocytosis (GO:0017157) | 3.01643905 |
| 73 | positive regulation of neurotransmitter transport (GO:0051590) | 3.01640295 |
| 74 | positive regulation of dendritic spine development (GO:0060999) | 2.99110010 |
| 75 | membrane depolarization during action potential (GO:0086010) | 2.97337736 |
| 76 | cellular sodium ion homeostasis (GO:0006883) | 2.94358542 |
| 77 | postsynaptic membrane organization (GO:0001941) | 2.92667101 |
| 78 | neuron cell-cell adhesion (GO:0007158) | 2.91563017 |
| 79 | neurotransmitter uptake (GO:0001504) | 2.90285693 |
| 80 | cell differentiation in hindbrain (GO:0021533) | 2.89247136 |
| 81 | vesicle docking involved in exocytosis (GO:0006904) | 2.87659975 |
| 82 | membrane depolarization (GO:0051899) | 2.87086716 |
| 83 | layer formation in cerebral cortex (GO:0021819) | 2.86916509 |
| 84 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.81846243 |
| 85 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.81501433 |
| 86 | regulation of synaptic transmission (GO:0050804) | 2.79803580 |
| 87 | positive regulation of Rap GTPase activity (GO:0032854) | 2.79099803 |
| 88 | establishment of synaptic vesicle localization (GO:0097480) | 2.74502339 |
| 89 | synaptic vesicle transport (GO:0048489) | 2.74502339 |
| 90 | acidic amino acid transport (GO:0015800) | 2.73240286 |
| 91 | regulation of beta-amyloid formation (GO:1902003) | 2.70704038 |
| 92 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.68215956 |
| 93 | regulation of dendritic spine development (GO:0060998) | 2.67080228 |
| 94 | synaptic transmission (GO:0007268) | 2.65873350 |
| 95 | positive regulation of exocytosis (GO:0045921) | 2.62989772 |
| 96 | signal complex assembly (GO:0007172) | 2.62501588 |
| 97 | regulation of Rap GTPase activity (GO:0032317) | 2.59469188 |
| 98 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.56074982 |
| 99 | auditory behavior (GO:0031223) | 2.52172935 |
| 100 | vesicle docking (GO:0048278) | 2.52147608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.77375848 |
| 2 | DROSHA_22980978_ChIP-Seq_HELA_Human | 3.19336270 |
| 3 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.77339229 |
| 4 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.71161248 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.61551702 |
| 6 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.56683573 |
| 7 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.55421956 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.43509093 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.39397378 |
| 10 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37382232 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.36883253 |
| 12 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.25962254 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.24980508 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.22852534 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20454765 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.09398959 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.99246855 |
| 18 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.96937863 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.91499210 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.88234116 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.87877238 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.84343534 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.84343534 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.81161499 |
| 25 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65724944 |
| 26 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.64747912 |
| 27 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.64352058 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.63401795 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58981947 |
| 30 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.57598273 |
| 31 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.57151063 |
| 32 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.52347289 |
| 33 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.52048872 |
| 34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51251192 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.43890476 |
| 36 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.39465734 |
| 37 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.38630284 |
| 38 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34728912 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29757707 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25810279 |
| 41 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25541516 |
| 42 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.24809171 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23540896 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23460445 |
| 45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22489763 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.18165415 |
| 47 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.16696864 |
| 48 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12709755 |
| 49 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.12556936 |
| 50 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11115751 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07482115 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07464421 |
| 53 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.07255773 |
| 54 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06472807 |
| 55 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.06111109 |
| 56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05639517 |
| 57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04993935 |
| 58 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.03639513 |
| 59 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02557510 |
| 60 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01605427 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01293687 |
| 62 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00540590 |
| 63 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99918941 |
| 64 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98911435 |
| 65 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98869625 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98218646 |
| 67 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96380276 |
| 68 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96149908 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95414295 |
| 70 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93916120 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92701308 |
| 72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92666289 |
| 73 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.92280900 |
| 74 | * AR_19668381_ChIP-Seq_PC3_Human | 0.91165242 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90556478 |
| 76 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89523088 |
| 77 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.89416359 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88857552 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87659475 |
| 80 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.87544281 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86853885 |
| 82 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.86113364 |
| 83 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85693726 |
| 84 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.83541918 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82377813 |
| 86 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82266257 |
| 87 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.81608085 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79994764 |
| 89 | * SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.79596898 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79406356 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78831262 |
| 92 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.76247012 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.76233364 |
| 94 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.74607401 |
| 95 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.74251628 |
| 96 | P68_20966046_ChIP-Seq_HELA_Human | 0.73757298 |
| 97 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73676790 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.72489264 |
| 99 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.71868146 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.71052598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.24081787 |
| 2 | MP0003880_abnormal_central_pattern | 4.74869124 |
| 3 | MP0004270_analgesia | 4.11094399 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.86275099 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.66589259 |
| 6 | MP0002064_seizures | 3.60462862 |
| 7 | MP0009745_abnormal_behavioral_response | 3.19331957 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.07261912 |
| 9 | MP0009046_muscle_twitch | 2.79777981 |
| 10 | MP0001486_abnormal_startle_reflex | 2.74732337 |
| 11 | MP0002272_abnormal_nervous_system | 2.72300092 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.58587183 |
| 13 | MP0003329_amyloid_beta_deposits | 2.57701539 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.56526029 |
| 15 | MP0008569_lethality_at_weaning | 2.56487052 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.51769669 |
| 17 | MP0003879_abnormal_hair_cell | 2.47852813 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.44938536 |
| 19 | MP0003690_abnormal_glial_cell | 2.25026917 |
| 20 | MP0003787_abnormal_imprinting | 1.93161938 |
| 21 | MP0001970_abnormal_pain_threshold | 1.85342165 |
| 22 | MP0002735_abnormal_chemical_nociception | 1.83700060 |
| 23 | MP0000920_abnormal_myelination | 1.80855637 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.76038894 |
| 25 | MP0003724_increased_susceptibility_to | 1.67506967 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.67414369 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.64650946 |
| 28 | MP0003633_abnormal_nervous_system | 1.64219802 |
| 29 | MP0001440_abnormal_grooming_behavior | 1.62467066 |
| 30 | MP0002736_abnormal_nociception_after | 1.58259725 |
| 31 | MP0000604_amyloidosis | 1.54455490 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.51973463 |
| 33 | MP0003075_altered_response_to | 1.43144370 |
| 34 | MP0004885_abnormal_endolymph | 1.43075955 |
| 35 | MP0003631_nervous_system_phenotype | 1.40009960 |
| 36 | MP0003303_peritoneal_inflammation | 1.39803860 |
| 37 | MP0002066_abnormal_motor_capabilities/c | 1.30459209 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.29835514 |
| 39 | MP0008874_decreased_physiological_sensi | 1.28154465 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.25688619 |
| 41 | MP0001502_abnormal_circadian_rhythm | 1.23883132 |
| 42 | MP0002557_abnormal_social/conspecific_i | 1.23673454 |
| 43 | MP0004924_abnormal_behavior | 1.21553079 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.21553079 |
| 45 | MP0001986_abnormal_taste_sensitivity | 1.20440777 |
| 46 | MP0003436_decreased_susceptibility_to | 1.18858726 |
| 47 | MP0004130_abnormal_muscle_cell | 1.17575968 |
| 48 | MP0004510_myositis | 1.13413119 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.11318655 |
| 50 | MP0004742_abnormal_vestibular_system | 1.09566661 |
| 51 | MP0001177_atelectasis | 1.07656814 |
| 52 | MP0003632_abnormal_nervous_system | 1.07578507 |
| 53 | MP0000569_abnormal_digit_pigmentation | 1.07415798 |
| 54 | MP0002229_neurodegeneration | 1.05847038 |
| 55 | MP0003634_abnormal_glial_cell | 1.03251889 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.03002196 |
| 57 | MP0008260_abnormal_autophagy | 0.99280765 |
| 58 | MP0003122_maternal_imprinting | 0.99060853 |
| 59 | MP0001905_abnormal_dopamine_level | 0.97737707 |
| 60 | MP0005535_abnormal_body_temperature | 0.97048644 |
| 61 | MP0000955_abnormal_spinal_cord | 0.95325896 |
| 62 | MP0006276_abnormal_autonomic_nervous | 0.95027442 |
| 63 | MP0004147_increased_porphyrin_level | 0.94292487 |
| 64 | MP0001348_abnormal_lacrimal_gland | 0.91929053 |
| 65 | MP0005166_decreased_susceptibility_to | 0.87415401 |
| 66 | MP0003045_fibrosis | 0.87177736 |
| 67 | MP0000778_abnormal_nervous_system | 0.86679140 |
| 68 | MP0003123_paternal_imprinting | 0.85794535 |
| 69 | MP0006082_CNS_inflammation | 0.83683992 |
| 70 | MP0002419_abnormal_innate_immunity | 0.81675466 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.80319891 |
| 72 | MP0001963_abnormal_hearing_physiology | 0.80020717 |
| 73 | MP0002822_catalepsy | 0.77717376 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.76429458 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 0.76380608 |
| 76 | MP0002152_abnormal_brain_morphology | 0.75910609 |
| 77 | MP0005000_abnormal_immune_tolerance | 0.75241330 |
| 78 | MP0001984_abnormal_olfaction | 0.75089576 |
| 79 | MP0008872_abnormal_physiological_respon | 0.74473618 |
| 80 | MP0003866_abnormal_defecation | 0.73600220 |
| 81 | MP0002184_abnormal_innervation | 0.72822313 |
| 82 | MP0005025_abnormal_response_to | 0.67805862 |
| 83 | MP0005671_abnormal_response_to | 0.67463757 |
| 84 | MP0002909_abnormal_adrenal_gland | 0.67437625 |
| 85 | MP0001851_eye_inflammation | 0.66592584 |
| 86 | MP0002133_abnormal_respiratory_system | 0.63981246 |
| 87 | MP0005388_respiratory_system_phenotype | 0.63981246 |
| 88 | MP0004142_abnormal_muscle_tone | 0.63634041 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.63404174 |
| 90 | MP0001835_abnormal_antigen_presentation | 0.63013625 |
| 91 | MP0004484_altered_response_of | 0.60340868 |
| 92 | MP0001533_abnormal_skeleton_physiology | 0.59385157 |
| 93 | MP0005409_darkened_coat_color | 0.58942456 |
| 94 | MP0002420_abnormal_adaptive_immunity | 0.56413321 |
| 95 | MP0001485_abnormal_pinna_reflex | 0.55580344 |
| 96 | MP0005551_abnormal_eye_electrophysiolog | 0.55195660 |
| 97 | MP0001819_abnormal_immune_cell | 0.54975081 |
| 98 | MP0002069_abnormal_eating/drinking_beha | 0.54851760 |
| 99 | MP0002723_abnormal_immune_serum | 0.54740346 |
| 100 | MP0001800_abnormal_humoral_immune | 0.52888271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.64326811 |
| 2 | Focal motor seizures (HP:0011153) | 6.45749337 |
| 3 | Focal seizures (HP:0007359) | 5.33299229 |
| 4 | Febrile seizures (HP:0002373) | 5.27138040 |
| 5 | Abnormality of binocular vision (HP:0011514) | 5.01107573 |
| 6 | Diplopia (HP:0000651) | 5.01107573 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 4.88089997 |
| 8 | Atonic seizures (HP:0010819) | 4.67448191 |
| 9 | Action tremor (HP:0002345) | 4.55609895 |
| 10 | Epileptic encephalopathy (HP:0200134) | 4.50732195 |
| 11 | Ankle clonus (HP:0011448) | 4.45980137 |
| 12 | Papilledema (HP:0001085) | 4.19358608 |
| 13 | Visual hallucinations (HP:0002367) | 4.13286013 |
| 14 | Hemiplegia (HP:0002301) | 4.02761651 |
| 15 | Postural instability (HP:0002172) | 3.96669504 |
| 16 | Neurofibrillary tangles (HP:0002185) | 3.90850036 |
| 17 | Mutism (HP:0002300) | 3.86685277 |
| 18 | Spastic gait (HP:0002064) | 3.72682999 |
| 19 | Obstructive sleep apnea (HP:0002870) | 3.62261383 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 3.54908084 |
| 21 | Abnormal eating behavior (HP:0100738) | 3.49162504 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.43704980 |
| 23 | Annular pancreas (HP:0001734) | 3.38557820 |
| 24 | Cerebral inclusion bodies (HP:0100314) | 3.28072662 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.22904649 |
| 26 | Neuronal loss in central nervous system (HP:0002529) | 3.20801870 |
| 27 | Tetraplegia (HP:0002445) | 3.20178677 |
| 28 | Absence seizures (HP:0002121) | 3.12372803 |
| 29 | Truncal ataxia (HP:0002078) | 3.09583446 |
| 30 | Torticollis (HP:0000473) | 3.06783587 |
| 31 | Dialeptic seizures (HP:0011146) | 3.03821623 |
| 32 | Intention tremor (HP:0002080) | 2.94219026 |
| 33 | Dysmetria (HP:0001310) | 2.92674838 |
| 34 | Depression (HP:0000716) | 2.82791716 |
| 35 | Ventricular fibrillation (HP:0001663) | 2.78831053 |
| 36 | Eczematoid dermatitis (HP:0000976) | 2.70525189 |
| 37 | Limb dystonia (HP:0002451) | 2.68748097 |
| 38 | Bradykinesia (HP:0002067) | 2.68245763 |
| 39 | Delusions (HP:0000746) | 2.62958956 |
| 40 | Lower limb muscle weakness (HP:0007340) | 2.60772594 |
| 41 | Focal dystonia (HP:0004373) | 2.55733586 |
| 42 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.54925995 |
| 43 | Clonus (HP:0002169) | 2.51333270 |
| 44 | Rigidity (HP:0002063) | 2.48829209 |
| 45 | Cerebral hypomyelination (HP:0006808) | 2.48481815 |
| 46 | Status epilepticus (HP:0002133) | 2.43762142 |
| 47 | Akinesia (HP:0002304) | 2.43131514 |
| 48 | Apathy (HP:0000741) | 2.41147314 |
| 49 | Slow saccadic eye movements (HP:0000514) | 2.41051031 |
| 50 | Peripheral hypomyelination (HP:0007182) | 2.40769537 |
| 51 | Abnormality of the corticospinal tract (HP:0002492) | 2.39944892 |
| 52 | Craniofacial dystonia (HP:0012179) | 2.38852153 |
| 53 | Rapidly progressive (HP:0003678) | 2.38695275 |
| 54 | Memory impairment (HP:0002354) | 2.33498213 |
| 55 | Impaired smooth pursuit (HP:0007772) | 2.32083016 |
| 56 | Anxiety (HP:0000739) | 2.31736613 |
| 57 | Urinary urgency (HP:0000012) | 2.30044823 |
| 58 | Scanning speech (HP:0002168) | 2.29131201 |
| 59 | Stereotypic behavior (HP:0000733) | 2.25110407 |
| 60 | Diminished motivation (HP:0000745) | 2.24315967 |
| 61 | Abnormality of saccadic eye movements (HP:0000570) | 2.22561868 |
| 62 | Myositis (HP:0100614) | 2.21466392 |
| 63 | Optic neuritis (HP:0100653) | 2.21152279 |
| 64 | Retrobulbar optic neuritis (HP:0100654) | 2.21152279 |
| 65 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.19826432 |
| 66 | Recurrent bacterial skin infections (HP:0005406) | 2.18880643 |
| 67 | Sleep apnea (HP:0010535) | 2.17910307 |
| 68 | Orchitis (HP:0100796) | 2.17727217 |
| 69 | Poor eye contact (HP:0000817) | 2.17268520 |
| 70 | Dysdiadochokinesis (HP:0002075) | 2.11155777 |
| 71 | Hemiparesis (HP:0001269) | 2.10953164 |
| 72 | Impaired vibratory sensation (HP:0002495) | 2.10458959 |
| 73 | Ocular albinism (HP:0001107) | 2.08847052 |
| 74 | Recurrent abscess formation (HP:0002722) | 2.07662692 |
| 75 | Epileptiform EEG discharges (HP:0011182) | 2.03887255 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.03367007 |
| 77 | Polyphagia (HP:0002591) | 2.03133290 |
| 78 | Spastic tetraparesis (HP:0001285) | 1.99782881 |
| 79 | Abnormality of macrophages (HP:0004311) | 1.99321145 |
| 80 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.96897003 |
| 81 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.96897003 |
| 82 | Iris hypopigmentation (HP:0007730) | 1.95693655 |
| 83 | Amyotrophic lateral sclerosis (HP:0007354) | 1.95449096 |
| 84 | Stomatitis (HP:0010280) | 1.94295211 |
| 85 | Spinal canal stenosis (HP:0003416) | 1.92808547 |
| 86 | Lower limb asymmetry (HP:0100559) | 1.89574634 |
| 87 | Abnormality of the periventricular white matter (HP:0002518) | 1.88272110 |
| 88 | Abnormality of the lower motor neuron (HP:0002366) | 1.87302359 |
| 89 | Abnormal social behavior (HP:0012433) | 1.84725581 |
| 90 | Impaired social interactions (HP:0000735) | 1.84725581 |
| 91 | Dementia (HP:0000726) | 1.81816420 |
| 92 | Vertigo (HP:0002321) | 1.80813299 |
| 93 | Amyloidosis (HP:0011034) | 1.80647625 |
| 94 | Abnormal EKG (HP:0003115) | 1.80490639 |
| 95 | Genetic anticipation (HP:0003743) | 1.78356722 |
| 96 | Episodic fever (HP:0001954) | 1.77910747 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 1.75415736 |
| 98 | Absent speech (HP:0001344) | 1.74437795 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73901985 |
| 100 | Choreoathetosis (HP:0001266) | 1.73650544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.05762528 |
| 2 | RIPK4 | 3.79570512 |
| 3 | DAPK2 | 3.73339001 |
| 4 | NTRK3 | 3.37409304 |
| 5 | PAK6 | 3.36531982 |
| 6 | CAMKK1 | 2.47170549 |
| 7 | MARK1 | 2.46747086 |
| 8 | NTRK2 | 2.32903822 |
| 9 | UHMK1 | 2.10670128 |
| 10 | PRPF4B | 2.07189747 |
| 11 | MAP3K9 | 2.03414944 |
| 12 | KSR2 | 1.86807527 |
| 13 | MINK1 | 1.75570518 |
| 14 | FES | 1.67552268 |
| 15 | CAMKK2 | 1.60489909 |
| 16 | RIPK1 | 1.56826833 |
| 17 | PRKD3 | 1.51646312 |
| 18 | SIK2 | 1.48661367 |
| 19 | GRK5 | 1.48471755 |
| 20 | CDK19 | 1.48334324 |
| 21 | TNK2 | 1.42355352 |
| 22 | MAP3K13 | 1.39242489 |
| 23 | MARK2 | 1.34742904 |
| 24 | CAMK1 | 1.32908291 |
| 25 | SGK223 | 1.30046789 |
| 26 | SGK494 | 1.30046789 |
| 27 | CDK5 | 1.28793222 |
| 28 | PRKCH | 1.27534918 |
| 29 | MAP3K11 | 1.26129683 |
| 30 | NTRK1 | 1.21030256 |
| 31 | SGK2 | 1.17197055 |
| 32 | STK38 | 1.14881614 |
| 33 | PDK1 | 1.14467268 |
| 34 | BMPR2 | 1.13653275 |
| 35 | SGK3 | 1.11402408 |
| 36 | MAPK12 | 1.11026486 |
| 37 | MAPK13 | 1.09986564 |
| 38 | ARAF | 1.07869356 |
| 39 | PLK2 | 1.06193437 |
| 40 | STK11 | 1.05085760 |
| 41 | DAPK1 | 1.04882671 |
| 42 | PDPK1 | 1.00788207 |
| 43 | PINK1 | 0.98327692 |
| 44 | NEK6 | 0.97501340 |
| 45 | BLK | 0.94933801 |
| 46 | GRK6 | 0.94825717 |
| 47 | MAP2K4 | 0.94634176 |
| 48 | WNK1 | 0.91032577 |
| 49 | JAK2 | 0.89265106 |
| 50 | DYRK1A | 0.88968842 |
| 51 | MAP3K1 | 0.88883903 |
| 52 | MAP3K2 | 0.85999736 |
| 53 | CAMK2B | 0.84967726 |
| 54 | TYRO3 | 0.84323832 |
| 55 | PAK3 | 0.84087174 |
| 56 | JAK1 | 0.84046175 |
| 57 | ALK | 0.83329140 |
| 58 | SYK | 0.82667000 |
| 59 | PRKCG | 0.79347643 |
| 60 | MAP2K3 | 0.78146010 |
| 61 | KSR1 | 0.78018010 |
| 62 | CAMK4 | 0.77766685 |
| 63 | SGK1 | 0.77210427 |
| 64 | CASK | 0.74638219 |
| 65 | OXSR1 | 0.73163141 |
| 66 | FYN | 0.71903753 |
| 67 | PHKG1 | 0.71302348 |
| 68 | PHKG2 | 0.71302348 |
| 69 | LATS2 | 0.70648267 |
| 70 | CDK15 | 0.67810285 |
| 71 | RET | 0.67108082 |
| 72 | CDK18 | 0.64818849 |
| 73 | PTK2B | 0.63654970 |
| 74 | CAMK2A | 0.63039612 |
| 75 | CDK14 | 0.62314843 |
| 76 | IRAK2 | 0.61636023 |
| 77 | TAOK1 | 0.60530041 |
| 78 | FGR | 0.60313984 |
| 79 | CSK | 0.59040345 |
| 80 | MAP4K1 | 0.58814009 |
| 81 | CDK11A | 0.58806823 |
| 82 | HCK | 0.58573541 |
| 83 | RAF1 | 0.57110116 |
| 84 | ZAP70 | 0.56030428 |
| 85 | PRKCZ | 0.54347560 |
| 86 | MAP2K6 | 0.51993674 |
| 87 | MAPK10 | 0.49643830 |
| 88 | TYK2 | 0.49011517 |
| 89 | CAMK2G | 0.47174490 |
| 90 | PKN1 | 0.43744001 |
| 91 | EPHB1 | 0.40053544 |
| 92 | PRKD2 | 0.39404234 |
| 93 | TAOK2 | 0.39286574 |
| 94 | PRKG2 | 0.39182085 |
| 95 | RPS6KA3 | 0.38809963 |
| 96 | ERBB2 | 0.36930417 |
| 97 | IRAK4 | 0.36045254 |
| 98 | TXK | 0.35510689 |
| 99 | ROCK2 | 0.35262567 |
| 100 | HIPK2 | 0.31794746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.50633352 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.20122374 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.66324108 |
| 4 | Morphine addiction_Homo sapiens_hsa05032 | 2.32199546 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.31296482 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.29546582 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.22894602 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.18960010 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.17881943 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.14694020 |
| 11 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.97906051 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.95038815 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.73366428 |
| 14 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.72630392 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67113070 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.60168285 |
| 17 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.54086238 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52847210 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51926822 |
| 20 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.47314435 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47275219 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.45165370 |
| 23 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41894750 |
| 24 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.38727997 |
| 25 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.38520773 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33596239 |
| 27 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32998943 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30102034 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.26119364 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.23526215 |
| 31 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.18667191 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18373780 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.17570886 |
| 34 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.14364816 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.12498478 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.07992851 |
| 37 | Olfactory transduction_Homo sapiens_hsa04740 | 1.07534330 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.03635575 |
| 39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.03055313 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02097003 |
| 41 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01861483 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98418172 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97011413 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95153589 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92536955 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92056492 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92053481 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91324078 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 0.91314488 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90089084 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89122946 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88025063 |
| 53 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86888506 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.85914692 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84606998 |
| 56 | Endocytosis_Homo sapiens_hsa04144 | 0.84348072 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 0.82608277 |
| 58 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77281133 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77233490 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76948794 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.75948928 |
| 62 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75899565 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75762239 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.74491257 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70277755 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70035234 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69991933 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69936540 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68568335 |
| 70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67430856 |
| 71 | Bile secretion_Homo sapiens_hsa04976 | 0.66288313 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.65789797 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64997855 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61244370 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60710631 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60668936 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57004970 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56206636 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55704015 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53027369 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.52990756 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50178674 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49026646 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.49017066 |
| 85 | Axon guidance_Homo sapiens_hsa04360 | 0.48027964 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45274564 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45088930 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44230546 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43014401 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41938112 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39983185 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38223962 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38035335 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.36531622 |
| 95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.36328172 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35831672 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34857418 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34448829 |
| 99 | Salmonella infection_Homo sapiens_hsa05132 | 0.34414254 |
| 100 | Phototransduction_Homo sapiens_hsa04744 | 0.33971530 |

